Search

Your search keyword '"Bergenstal, R. M."' showing total 92 results

Search Constraints

Start Over You searched for: Author "Bergenstal, R. M." Remove constraint Author: "Bergenstal, R. M."
92 results on '"Bergenstal, R. M."'

Search Results

12. Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial

13. LEADER 2:baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations

14. Liraglutide and cardiovascular outcomes in type 2 diabetes

15. Differences in the Management of Type 1 Diabetes Among Adults Under Excellent Control Compared With Those Under Poor Control in the T1D Exchange Clinic Registry

16. Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits

18. Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140-2147

20. Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

22. Diabetes and Cancer: A Consensus Report

24. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

26. Use of an automated device for alternative site blood glucose monitoring.

31. Familial hyperproinsulinemia: partial characterization of circulating proinsulin-like material.

32. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

33. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study

34. Alogliptin after acute coronary syndrome in patients with type 2 diabetes

36. 40 EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

37. The Metabolic Effects of Biosynthetic Human Proinsulin in Individuals with Type I Diabetes*

41. Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3.

42. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range

43. Liraglutide and cardiovascular outcomes in type 2 diabetes

44. Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naïve people with type 2 diabetes: 12-month results from the EDITION 3 trial.

45. Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes.

46. Comprehensive management of patients with type 2 diabetes: establishing priorities of care.

47. Optimization of insulin therapy in patients with type 2 diabetes.

48. Familial hyperinsulinemia due to a structurally abnormal insulin. Definition of an emerging new clinical syndrome.

49. Diabetic ketoacidosis. How to treat and, when possible, prevent.

50. Dietary practices of persons with diabetes during insulin pump therapy.

Catalog

Books, media, physical & digital resources